Literature DB >> 21978892

BAX unleashed: the biochemical transformation of an inactive cytosolic monomer into a toxic mitochondrial pore.

Loren D Walensky1, Evripidis Gavathiotis.   

Abstract

BAX, the BCL-2-associated X protein, is a cardinal proapoptotic member of the BCL-2 family, which regulates the critical balance between cellular life and death. Because so many medical conditions can be categorized as diseases of either too many or too few cells, dissecting the biochemistry of BCL-2 family proteins and developing pharmacological strategies to target them have become high priority scientific objectives. Here, we focus on BAX, a latent, cytosolic and monomeric protein that transforms into a lethal mitochondrial oligomer in response to cellular stress. New insights into the structural location of BAX's 'on switch', and the multi-step conformational changes that ensue upon BAX activation, are providing fresh opportunities to modulate BAX for potential benefit in human diseases characterized by pathologic cell survival or unwanted cellular demise.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21978892      PMCID: PMC3454508          DOI: 10.1016/j.tibs.2011.08.009

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  113 in total

1.  Bcl-2 and Bax interact via the BH1-3 groove-BH3 motif interface and a novel interface involving the BH4 motif.

Authors:  Jingzhen Ding; Zhi Zhang; G Jane Roberts; Mina Falcone; Yiwei Miao; Yuanlong Shao; Xuejun C Zhang; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2010-06-28       Impact factor: 5.157

2.  BH3-triggered structural reorganization drives the activation of proapoptotic BAX.

Authors:  Evripidis Gavathiotis; Denis E Reyna; Marguerite L Davis; Gregory H Bird; Loren D Walensky
Journal:  Mol Cell       Date:  2010-11-12       Impact factor: 17.970

3.  Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity.

Authors:  Wyndham H Wilson; Owen A O'Connor; Myron S Czuczman; Ann S LaCasce; John F Gerecitano; John P Leonard; Anil Tulpule; Kieron Dunleavy; Hao Xiong; Yi-Lin Chiu; Yue Cui; Todd Busman; Steven W Elmore; Saul H Rosenberg; Andrew P Krivoshik; Sari H Enschede; Rod A Humerickhouse
Journal:  Lancet Oncol       Date:  2010-11-18       Impact factor: 41.316

4.  Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax.

Authors:  Jonathan F Lovell; Lieven P Billen; Scott Bindner; Aisha Shamas-Din; Cecile Fradin; Brian Leber; David W Andrews
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

5.  Molecular details of Bax activation, oligomerization, and membrane insertion.

Authors:  Stephanie Bleicken; Mirjam Classen; Pulagam V L Padmavathi; Takashi Ishikawa; Kornelius Zeth; Heinz-Jürgen Steinhoff; Enrica Bordignon
Journal:  J Biol Chem       Date:  2009-12-12       Impact factor: 5.157

6.  Bax contains two functional mitochondrial targeting sequences and translocates to mitochondria in a conformational change- and homo-oligomerization-driven process.

Authors:  Nicholas M George; Natalie Targy; Jacquelynn J D Evans; Liqiang Zhang; Xu Luo
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

7.  Inhibition of Bak activation by VDAC2 is dependent on the Bak transmembrane anchor.

Authors:  Michael Lazarou; Diana Stojanovski; Ann E Frazier; Aneta Kotevski; Grant Dewson; William J Craigen; Ruth M Kluck; David L Vaux; Michael T Ryan
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

8.  Bak activation for apoptosis involves oligomerization of dimers via their alpha6 helices.

Authors:  Grant Dewson; Tobias Kratina; Peter Czabotar; Catherine L Day; Jerry M Adams; Ruth M Kluck
Journal:  Mol Cell       Date:  2009-11-25       Impact factor: 17.970

9.  Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis.

Authors:  Hyungjin Kim; Ho-Chou Tu; Decheng Ren; Osamu Takeuchi; John R Jeffers; Gerard P Zambetti; James J-D Hsieh; Emily H-Y Cheng
Journal:  Mol Cell       Date:  2009-11-13       Impact factor: 17.970

10.  The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer.

Authors:  Michelle L Stewart; Emiko Fire; Amy E Keating; Loren D Walensky
Journal:  Nat Chem Biol       Date:  2010-06-20       Impact factor: 15.040

View more
  82 in total

1.  Natural compound Alternol induces oxidative stress-dependent apoptotic cell death preferentially in prostate cancer cells.

Authors:  Yuzhe Tang; Ruibao Chen; Yan Huang; Guodong Li; Yiling Huang; Jiepeng Chen; Lili Duan; Bao-Ting Zhu; J Brantley Thrasher; Xu Zhang; Benyi Li
Journal:  Mol Cancer Ther       Date:  2014-03-31       Impact factor: 6.261

2.  Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells.

Authors:  Shumin Zhang; Yanru Wang; Zhengjia Chen; Sungjin Kim; Shareen Iqbal; Andrew Chi; Chad Ritenour; Yongqiang A Wang; Omer Kucuk; Daqing Wu
Journal:  Prostate       Date:  2013-09-02       Impact factor: 4.104

Review 3.  Mechanisms of cell death in heart disease.

Authors:  Klitos Konstantinidis; Russell S Whelan; Richard N Kitsis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-17       Impact factor: 8.311

Review 4.  Bacterial programmed cell death: making sense of a paradox.

Authors:  Kenneth W Bayles
Journal:  Nat Rev Microbiol       Date:  2014-01       Impact factor: 60.633

Review 5.  Computational studies of peptide-induced membrane pore formation.

Authors:  Richard Lipkin; Themis Lazaridis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-08-05       Impact factor: 6.237

6.  Distinct BimBH3 (BimSAHB) stapled peptides for structural and cellular studies.

Authors:  Greg H Bird; Evripidis Gavathiotis; James L LaBelle; Samuel G Katz; Loren D Walensky
Journal:  ACS Chem Biol       Date:  2014-01-03       Impact factor: 5.100

7.  Structural insight into BH3 domain binding of vaccinia virus antiapoptotic F1L.

Authors:  Stephanie Campbell; John Thibault; Ninad Mehta; Peter M Colman; Michele Barry; Marc Kvansakul
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

8.  The effect of aging on mitochondrial and cytosolic hepatic intrinsic death pathway and apoptosis associated proteins in Fischer 344 rats.

Authors:  John Mach; Aniko Huizer-Pajkos; Alice Kane; Brett Jones; Catriona McKenzie; Sarah J Mitchell; Rafael de Cabo; Victoria C Cogger; David G Le Couteur; Sarah N Hilmer
Journal:  Exp Gerontol       Date:  2015-04-22       Impact factor: 4.032

Review 9.  Axon degeneration: context defines distinct pathways.

Authors:  Matthew J Geden; Mohanish Deshmukh
Journal:  Curr Opin Neurobiol       Date:  2016-05-16       Impact factor: 6.627

10.  The retinoblastoma protein induces apoptosis directly at the mitochondria.

Authors:  Keren I Hilgendorf; Elizaveta S Leshchiner; Simona Nedelcu; Mindy A Maynard; Eliezer Calo; Alessandra Ianari; Loren D Walensky; Jacqueline A Lees
Journal:  Genes Dev       Date:  2013-04-25       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.